(click on the image above to view the video)
This presentation was recorded at the IMF Satellite Symposium held at the 2019 Oncology Nursing Society’s annual meeting. In this video Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN (Taussig Cancer Institute, Cleveland Clinic - Cleveland), Joseph D. Tariman, PhD, RN, ANP-BC, FAAN (De Paul University - Chicago), Sandra Rome RN, MN, AOCN, CNS (Cedars-Sinai Medical Center - Los Angeles), and Kimberly Noonan, DNP, RN, ANP-BC, AOCN (Dana-Farber Cancer Institute - Boston), address key issues in multiple myeloma nursing.
This Nurse Leadership Board presentation covers the following topics: Updates in smoldering multiple myeloma research, bone health, renal health, minimal residual disease, survivorship care, relapse, and drugs currently in development.
- Multiple Myeloma Background, Shared Decision Making, and Smoldering MM Research Update
- Newly Diagnosed Multiple Myeloma, Response, Bone Health, Renal Health, MRD, Survivorship Care
- Relapsed Myeloma, Treatment for Relapsed Myeloma, Drugs in Development, Knowledge Post-Test
This activity is supported by educational grants provided by Takeda Oncology, Celgene Corporation, Karyopharm Therapeutics Inc., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.